Angiotensin-(1-7) inhibits angiotensin II-induced signal transduction

Journal of Cardiovascular Pharmacology

Volumn 40, Issue 5, 2002, Pages 693-700

  Zhu, Zhiming ^a,b   Zhong, Jian ^a,b   Zhu, Shanjun ^a,b   Liu, Daoyan ^a,b   Van der Giet, Markus ^a,b   Tepel, Martin ^a,b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Angiotensin II; Angiotensin (1 7); Extracellular signal regulated kinases; Receptors; Vascular smooth muscle

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; ANGIOTENSIN[1-7]; ANTIBODY; LEUCINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1 ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE 2 ANTIBODY; PROTEIN KINASE C; PROTEIN KINASE C ANTIBODY; RECEPTOR SUBTYPE; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVATION; HEMODYNAMICS; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR RING; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; WESTERN BLOTTING;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; ENZYME ACTIVATION; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 0036872354     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200211000-00007     Document Type: Article

References (33)

1. Santos RAS, Brosnihan KB, Jacobsen DW, et al. Production of angiotensin (1-7) by human vascular endothelium. Hypertension 1992;19:II56-61.
2. Tallant EA, Diz DI, Ferrario CM. Antiproliferative actions of angiotensin-(1-7) in vascular smooth muscle. Hypertension 1999;34:950-7.
3. Luque M, Martin P, Martell N, et al. Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension. J Hypertens 1996;14:799-805.
4. Gorelik G, Carbini LA, Scicli AG. Angiotensin-(1-7) induces bradykinin-mediated relaxation in porcine coronary artery. J Pharmacol Exp Ther 1998;286:403-10.
5. Roks AJM, van Geel PP, Pinto YM, et al. Angiotensin-(1-7) is a modulator of the human renin-angiotensin system. Hypertension 1999;34:296-301.
6. Paula RD, Lima CV, Khosla MC, et al. Angiotensin-(1-7) potentiates the hypotensive effect of bradykinin in conscious rats. Hypertension 1995;26:1154-9.
7. Lima CV, Paula RD, Resende FL, et al. Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1-7) in normotensive and hypertensive rats. Hypertension 1997;30:542-8.
8. Widdop RE, Sampey DB, Jarrott B. Cardiovascular effects of angiotensin-(1-7) in conscious spontaneously hypertensive rats. Hypertension 1999;34:964-8.
9. Iyer SN, Averill DB, Chappell MC, et al. Contribution of angiotensin-(1-7) to blood pressure regulation in salt-depleted hypertensive rats. Hypertension 2000;36:417-22.
10. Ueda S, Masumori-Maemoto S, Shino K, et al. Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man. Hypertension 2000; 35:998-1001.
11. Wilsdorf T, Gainer JV, Murphey LJ, et al. Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm. Hypertension 2001;37: 1136-40.
12. Freeman EJ, Chisolm GM, Ferrario CM, et al. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension 1996;28:104-8.
13. Strawn BS, Ferrario CM, Tallant EA. Angiotensin-(1-7) reduces smooth muscle growth after vascular injury. Hypertension 1999;33:207-11.
14. Li P, Chappell MC, Ferrario CM, et al. Angiotensin (1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension 1997; 29:542-8.
15. Heitsch H, Brovkovych S, Malinski T, et al. Angiotensin-(1-7)-stimulated nitric oxide and superoxide release from endothelial cells. Hypertension 2001;37:72-6.
16. Symons JD, Musch TI, Hageman KS, et al. Regional blood flow responses to acute AngII infusion: Effects of nitric oxide synthase inhibition. J Cardiovasc Pharmacol 1999; 34:116-23.
17. Benter IF, Ferrario CM, Morris M, et al. Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats. Am J Physiol 1995;269:H313-9.
18. LeTran Y, Forster C. Angiotensin-(1-7) and the rat aorta: Modulation by the endothelium. J Cardiovasc Pharmacol 1997;30:676-82.
19. 2+ in vascular smooth muscle cells. Am J Physiol 1994;266: C794-9.
20. Neusser M, Golinski P, Zhu Z, et al. Thapsigargin-insensitive intracellular calcium pools in vascular smooth muscle cells. Clin Exp Hypertens 1999;21:395-405.
21. Touyz RM, Deng LY, He G, et al. Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: Role of extracellular signal-related kinases. J Hypertens 1999;17:907-16.
22. Liao DF, Monia B, Dean N, et al. Protein kinase C-zeta mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells. J Biol Chem 1997;272:6146-50.
23. Ruan XP, Wagner C, Chatziantoniou C, et al. Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet. J Clin Invest 1997;99:1072-81.
24. Zhu Z, Zhang SH, Wagner C, et al. Angiotensin AT1B receptor mediates calcium signaling in vascular smooth muscle cells of AT1A receptor-deficient mice. Hypertension 1998;31:1171-7.
25. Chomczynski P, Sacci N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
26. Mahon JM, Carr RD, Nicol AK, et al. Angiotensin-(1-7) is an antagonist at the type 1 angiotensin II receptor. J Hypertens 1994;12:1377-81.
27. Fernandes L, Fortes ZB, Nigro D, et al. Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo. Hypertension 2001;37:703-9.
28. Adams B, Obertone TS, Wang X, et al. Relationship between internalization and mRNA decay in downregulation of recombinant type 1 angiotensin II receptor (AT1) expression in smooth muscle cells. Mol Pharmacol 1999;55: 1028-36.
29. Griendling KK, Delafontaine P, Rittenhouse SE, et al. Correlation of receptor sequestration with sustained diacylglycerol accumulation in angiotensin II-stimulated cultured vascular smooth muscle cells. J Biol Chem 1987;262: 14555-62.
30. Thomas WG, Thekkumkara TJ, Motel TJ, et al. Stable expression of a truncated AT1A receptor in CHO-K1 cells: The carboxyl-terminal region directs agonist-induced internalization but not receptor signaling or desensitization. J Biol Chem 1995;270:207-13.
31. Lassegue B, Alexander RW, Nickenig G, et al. Angiotensin II downregulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: Evidence for homologous and heterologous regulation. Mol Pharmacol 1995;48:601-9.
32. Wang X, Murphy TJ. Inhibition of cyclic AMP-dependent kinase by expression of a protein kinase inhibitor/enhanced green fluorescent fusion protein attenuates angiotensin II-induced type 1 AT1 receptor mRNA downregulation in vascular smooth muscle cells. Mol Pharmacol 1998;54: 514-24.
33. Ichiki T, Takeda K, Tokunou T, et al. Reactive oxygen species-mediated homologous downregulation of angiotensin II type 1 receptor mRNA by angiotensin II. Hypertension 2001;37:535-40.